User menu

Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.

Bibliographic reference Verreth, Wim ; De Keyzer, D ; Davey, P C ; Geeraert, B ; Mertens, A. ; et. al. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.. In: British journal of pharmacology, Vol. 151, no. 3, p. 347-55 (2007)
Permanent URL http://hdl.handle.net/2078.1/28573
  1. Argmann, J Biol Chem, 280, 22212 (2005)
  2. Chawla, Mol Cell, 7, 161 (2001)
  3. Costa, Diabet Med, 20, 743 (2003)
  4. Crisby M., Nordin-Fredriksson G., Shah P. K., Yano J., Zhu J., Nilsson J., Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques : Implications for Plaque Stabilization, 10.1161/01.cir.103.7.926
  5. Didion, Circ Res, 91, 938 (2002)
  6. Fang X., Weintraub N. L., Rios C. D., Chappell D. A., Zwacka R. M., Engelhardt J. F., Oberley L. W., Yan T., Heistad D. D., Spector A. A., Overexpression of Human Superoxide Dismutase Inhibits Oxidation of Low-Density Lipoprotein by Endothelial Cells, 10.1161/01.res.82.12.1289
  7. Faraci, Arterioscler Thromb Vasc Biol, 24, 1367 (2004)
  8. Fukushima, Cardiovasc Res, 69, 459 (2006)
  9. Grip, Inflamm Res, 51, 58 (2002)
  10. Guclu, Biomed Pharmacother, 58, 614 (2004)
  11. Hasty, J Biol Chem, 276, 37402 (2001)
  12. Holvoet, Arterioscler Thromb Vasc Biol, 26, 1558 (2006)
  13. Holvoet, Diabetes, 53, 1068 (2004)
  14. Holvoet P., Vanhaecke J., Janssens S., Van de Werf F., Collen D., Oxidized LDL and Malondialdehyde-Modified LDL in Patients With Acute Coronary Syndromes and Stable Coronary Artery Disease, 10.1161/01.cir.98.15.1487
  15. Inoue, Life Sci, 67, 863 (2000)
  16. Kleemann, Circulation, 108, 1368 (2003)
  17. Libby, Am J Cardiol, 91, 4B (2003)
  18. Ludwig, J Clin Invest, 107, 379 (2001)
  19. Lundbye, Curr Atheroscler Rep, 7, 17 (2005)
  20. Mackness, Arterioscler Thromb Vasc Biol, 26, 1545 (2006)
  21. Mertens, Circulation, 107, 1640 (2003)
  22. Paniagua, Diabetes, 51, 2596 (2002)
  23. Parker, Atherosclerosis, 169, 19 (2003)
  24. Rosenson, Atherosclerosis, 173, 1 (2004)
  25. Schonbeck, Circulation, 109, II18 (2004)
  26. Sonmez, Endocrine, 22, 151 (2003)
  27. Staels, Curr Med Res Opin, 21, S13 (2005)
  28. Stoll, Timely Top Med Cardiovasc Dis, 9, E1 (2005)
  29. Takemoto, Arterioscler Thromb Vasc Biol, 21, 1712 (2001)
  30. Tanaka, Circulation, 110, II200 (2004)
  31. Tsimikas, N Engl J Med, 353, 46 (2005)
  32. Tsimikas S., Palinski W., Witztum J. L., Circulating Autoantibodies to Oxidized LDL Correlate With Arterial Accumulation and Depletion of Oxidized LDL in LDL Receptor-Deficient Mice, 10.1161/01.atv.21.1.95
  33. Umeji, Am J Physiol Heart Circ Physiol, 291, H2522 (2006)
  34. Usui, J Lipid Res, 43, 805 (2002)
  35. Eck, J Biol Chem, 278, 23699 (2003)
  36. Verreth, Circulation, 110, 3259 (2004)
  37. Verreth, Arterioscler Thromb Vasc Biol, 26, 922 (2006)
  38. Wagner A. H., Kohler T., Ruckschloss U., Just I., Hecker M., Improvement of Nitric Oxide-Dependent Vasodilatation by HMG-CoA Reductase Inhibitors Through Attenuation of Endothelial Superoxide Anion Formation, 10.1161/01.atv.20.1.61
  39. Wang, Proc Natl Acad Sci USA, 95, 4556 (1998)